Found: 12
Select item for more details and to access through your institution.
Yellow Fever Vaccine–Associated Viscerotropic Disease among Siblings, São Paulo State, Brazil .
- Published in:
- Emerging Infectious Diseases, 2023, v. 29, n. 3, p. 493, doi. 10.3201/eid2903.220989
- By:
- Publication type:
- Article
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers.
- Published in:
- BMC Pharmacology & Toxicology, 2018, v. 19, p. 1, doi. 10.1186/s40360-017-0192-z
- By:
- Publication type:
- Article
Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2021, v. 11, p. 1, doi. 10.3389/fcimb.2021.656393
- By:
- Publication type:
- Article
17DD and 17D-213/77 Yellow Fever Substrains Trigger a Balanced Cytokine Profile in Primary Vaccinated Children.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0049828
- By:
- Publication type:
- Article
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline.
- Published in:
- BMC Infectious Diseases, 2014, v. 14, n. 1, p. 391, doi. 10.1186/1471-2334-14-391
- By:
- Publication type:
- Article
Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination.
- Published in:
- PLoS Neglected Tropical Diseases, 2018, v. 12, n. 6, p. 1, doi. 10.1371/journal.pntd.0006462
- By:
- Publication type:
- Article
Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01382
- By:
- Publication type:
- Article
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02192
- By:
- Publication type:
- Article
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01211
- By:
- Publication type:
- Article
Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1854-6
- By:
- Publication type:
- Article
Cytokine Signatures of Innate and Adaptive Immunity in 17DD Yellow Fever Vaccinated Children and Its Association With the Level of Neutralizing Antibody.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 6, p. 873, doi. 10.1093/infdis/jir439
- By:
- Publication type:
- Article